Texto: 
pathology: 
 - cd20 positive small lymphoid cells and plasmacytic cells
 - cd3 less frequent, positive in 1/3 of lymphoid cells
 - cd5, cd10 negative
 - in situ hybridization – monoclonal lambda positive
low grade b-cell lymphoma malt type with plasmacytic differentiation
low grade b-cell lymphoma malt type with plasmacytic differentiation
radiation to eye and orbit
persistence of subretinal deposits

body and head mri unremarkable

lp normal

vitrectomy: scant cells consistent with chronic inflammation.  no cytologic atypia or monoclonal b cell population

no definite response to systemic steroids

variable visual acuity 20/20-20/40

94 weeks

increasing subretinal fluid
is the choroid a primary site for involvement with lymphoproliferative neoplasms?
what is the spectrum of lymphoproliferative neoplasms occurring at that site?


Keywords by value: 
- plasmacytic: 0.21157244217519597 (3)
- subretinal: 0.14104829478346398 (2)
- malt: 0.11886758500554573 (10)
- lymphoproliferative: 0.11529728818451837 (6)
- cells: 0.10964629421279992 (362)
- monoclonal: 0.10589270154608446 (15)
- lymphoid: 0.09668687522762746 (20)
- b-cell: 0.08510417380000028 (48)
- differentiation: 0.07284541675080293 (81)
- hybridization: 0.07052414739173199 (1)
- 20/20-20/40: 0.07052414739173199 (1)
- neoplasms: 0.06959376488499064 (110)
- positive: 0.0665492541668188 (589)
- cd3: 0.06173524908238711 (11)
- cd5: 0.059433792502772864 (10)
- vitrectomy: 0.059433792502772864 (6)
- -: 0.05861531067866763 (21459)
- site: 0.057784187790235246 (415)
- cd10: 0.057648644092259185 (9)
- lambda: 0.05619007163790755 (11)
- cd20: 0.05495686619928948 (12)
- cytologic: 0.05495686619928948 (7)
- atypia: 0.0538886150582933 (8)
- ?: 0.05335807200999211 (590)
- grade: 0.05207738868721552 (661)
- scant: 0.05134098520934502 (11)
- 94: 0.048859745782914306 (121)
- lp: 0.04785844063928226 (1664)
- type: 0.04608998765355057 (949)
- persistence: 0.04544019366429879 (26)
- 1/3: 0.04445937508756013 (43)
- situ: 0.04445937508756013 (137)
- deposits: 0.04415745246369735 (44)
- acuity: 0.04305224975585082 (37)
- spectrum: 0.03955453930446886 (59)
- lymphoma: 0.039075178150231774 (867)
- occurring: 0.03817973724905559 (68)
- low: 0.038018688845862396 (6753)
- definite: 0.03700690945552058 (86)
- variable: 0.036422708375401465 (83)
- what: 0.03609162664609863 (210)
- population: 0.035670476778215256 (110)
- choroid: 0.03488936902170392 (217)
- orbit: 0.03443727133959719 (533)
- response: 0.034263351446505934 (137)
- frequent: 0.03417778913357196 (314)
- systemic: 0.03270504484203326 (160)
- b: 0.03222421344947562 (78355)
- steroids: 0.032157823026958056 (185)
- visual: 0.03099100801085755 (597)
- –: 0.03076564099512398 (572)
- inflammation: 0.029069878989395306 (226)
- eye: 0.02867527845689529 (547)
- increasing: 0.028018499559397687 (234)
- pathology: 0.027979187440978256 (310)
- involvement: 0.025055509253022534 (401)
- less: 0.02315152003458146 (774)
- unremarkable: 0.022632531349456485 (465)
- radiation: 0.02243400999649869 (533)
- body: 0.022202109701512675 (675)
- negative: 0.020416961290998993 (803)
- primary: 0.02025107410316557 (748)
- fluid: 0.019429112836830825 (1076)
- weeks: 0.019402222055209188 (793)
- head: 0.01938881048459117 (1929)
- chronic: 0.019255917063256 (888)
- cell: 0.018465925692651892 (1988)
- :: 0.018084397055850642 (11095)
- consistent: 0.016762386150649625 (1064)
- small: 0.01574860227504895 (1623)
- mri: 0.01570620683931696 (1820)
- no: 0.013767106411260832 (35870)
- that: 0.011807845828470586 (3273)
- normal: 0.010716899636792808 (4858)
- at: 0.009262105222653064 (83424)
- is: 0.00899665245415561 (65037)
- or: 0.00801218199170966 (60128)
- to: 0.00683308973508778 (40381)
- in: 0.006742355682244079 (113220)
- for: 0.005832865189141721 (12260)
- ,: 0.004331361048276599 (45533)
- and: 0.004320216137573243 (31978)
- with: 0.0037441336348764715 (23954)
- a: 0.0031727984145488103 (549576)
- of: 0.0027960912191517225 (41955)
- the: 0.002211988555258013 (67588)
- .: 0.0002839962887787702 (82185)
